INH preventive therapy (IPT) in HIV-infected south African children

Southern African Journal of HIV Medicine

Volumn , Issue 40, 2011, Pages 27-30

  Cotton, Mark F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ISONIAZID; PYRIDOXINE;

ANTIVIRAL THERAPY; CHEMOPROPHYLAXIS; CHILDHOOD DISEASE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; ISONIAZID PREVENTIVE THERAPY; PATIENT ASSESSMENT; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; REVIEW; RISK REDUCTION; SOUTH AFRICA; TUBERCULOSIS; TUBERCULOSIS CONTROL; VITAMIN SUPPLEMENTATION;

EID: 79959948833     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: 10.4102/sajhivmed.v12i2.195     Document Type: Review

References (17)

1. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007;334:136.
2. World Health Organization. WHO Three I's Meeting (2-4 April 2008). Geneva: WHO, 2008
3. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons (Review). Cochrane Collection 2010. www.thecochranelibrary.com (accessed 18 January 2011).
4. Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ, Churchyard GJ. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis 2010;10:489-498
5. Balcells ME, Thomas SL, Godfrey-Faussett P, Grant AD. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis 2006;12:744-751. (Pubitemid 43726847)
6. Sneag DB, Schaaf HS, Cotton MF, Zar HJ. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J 2007;26:1142-1146. (Pubitemid 350190948)
7. United States Public Health Service Tuberculosis Prophylaxis Trial Collaborators. Prophylactic effects of isoniazid on primary tuberculosis in children. Am Rev Tuberc 1957;76:942-963.
8. Madhi SA, McSherry G, Violari A, et al. Lack of efficacy of primary isoniazid (INH) prophylaxis in reducing tuberculosis (TB) free survival in HIV-infected (HIV+) African children. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy, 25-28th October 2008. Washington DC: IDSA/ASM. http://clinicaloptions.com/hiv/washington2008 (accessed 11 May 2011).
9. Mitchell C, McSherry G, Violari A, et al. Primary isoniazid prophylaxis did not protect against TB or latent TB infection in HIV-exposed, uninfected infants in South Africa. Presented at the 16th Conference on Retrovirology and Opportunistic Infections, 8-11 February 2009, Montreal, Canada, http://www.retroconference.org/ (accessed 11 May 2011).
10. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008:359:2233-2244.
11. Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy BMC Pediatr 2008;8.1.
12. Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax 2011 (in press, e-pub date 2 April).
13. World Health Organization. Guidelines for Intensified Ttuberculosis Case-finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-constrained Settings. Geneva: WHO, 2011.
14. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: Evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009;48:108-114.
15. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 2000;356:1470-1474.
16. World Health Organization, International Union Against Tuberculosis and Lung Disease. Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV-infected children. Recommendations for a public health approach. 2010. www.idoc-africa.org/documents/download/id/206 (accessed 15 April 2011).
17. Al-Dabbagh M, Lapphra K, McGloin R, et al. Drug-resistant tuberculosis. Pediatr Infect Dis J 2011 (in press, e-pub date 3 February).